SightfileU.S. market data from official filings

Companies › NEPH

NEPHROS INC (NEPH)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001196298 · EDGAR filings · Updated 2026-06-15

NEPHROS INC (NEPH) has reported institutional ownership of 50.5%, with 27 institutional managers holding positions valued at $16.0M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
50.5%
Institutional managers
27
Reported 13F value
$16.0M
Insider activity
6 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEPHROS INC has 27 institutional holders and institutional ownership of 50.5%.

Insider activity

Insiders reported 6 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2023-08-09 (recurring since 2022-08-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

XILIO THERAPEUTICS INC (XLO) · TALPHERA INC (TLPH) · Cognition Therapeutics Inc (CGTX) · ELUTIA INC (ELUT) · GAIN THERAPEUTICS INC (GANX) · SENSUS HEALTHCARE INC (SRTS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.